GILD

Gilead Sciences Inc

May 15 • 04:00PM ET

129.58

-2.48 -1.88 %

Healthcare • Drug Manufacturers - General • USA • Large • NASD

Peers: BMY PFE ABBV MRK AZN NVS LLY SNY AMGN TAK

| Held by: VTI VOO QQQ IVV SPY VTV XLV VIG QQQM VYM

Scroll to Statements

Index	NDX, S&P 500	P/E	17.63	EPS (ttm)	7.35	Insider Own	0.15%	Shs Outstand	1.24B	Perf Week	-1.33%
Market Cap	160.88B	Forward P/E	13.46	EPS next Y	9.62	Insider Trans	-17.40%	Shs Float	1.24B	Perf Month	-6.47%
Enterprise Value	173.16B	PEG	1.51	EPS next Q	-6.60	Inst Own	89.01%	Short Float	1.86%	Perf Quarter	-16.39%
Income	9.22B	P/S	5.40	EPS this Y	-88.23%	Inst Trans	-0.18%	Short Ratio	3.73	Perf Half Y	5.01%
Sales	29.79B	P/B	6.84	EPS next Y	902.92%	ROA	16.35%	Short Interest	23.05M	Perf YTD	5.57%
Book/sh	18.93	P/C	16.39	EPS next 5Y	8.93%	ROE	43.19%	52W High	157.29 -17.62%	Perf Year	29.14%
Cash/sh	7.91	P/FCF	15.73	EPS past 3/5Y	23.06% 133.64%	ROIC	20.77%	52W Low	97.86 32.41%	Perf 3Y	65.32%
Dividend Est.	3.25 (2.51%)	EV/EBITDA	11.73	Sales past 3/5Y	2.83% 3.63%	Gross Margin	79.41%	Volatility	2.80% 2.42%	Perf 5Y	89.09%
Dividend TTM	3.19 (2.46%)	EV/Sales	5.81	EPS Y/Y TTM	55.01%	Oper. Margin	40.41%	ATR (14)	3.35	Perf 10Y	56.69%
Dividend Ex-Date	Jun 15, 2026	Quick Ratio	1.77	Sales Y/Y TTM	3.83%	Profit Margin	30.94%	RSI (14)	39.62	Recom	1.66
Dividend Gr. 3/5Y	2.67% 3.04%	Current Ratio	1.97	EPS Q/Q	54.29%	SMA20	-2.04%	Beta	0.33	Target Price	160.56
Payout	46.60%	Debt/Eq	0.94	Sales Q/Q	5.09%	SMA50	-5.66%	Rel Volume	1.07	Prev Close	132.06
Employees	17000	LT Debt/Eq	0.89	Earnings	May 07 AMC	SMA200	1.35%	Avg Volume	6.18M	Price	129.58
IPO	Jan 22, 1992	Option/Short	Yes / Yes	EPS/Sales Surpr.	6.31% 0.67%	Trades		Volume	6,639,982	Change	-1.88%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)